Mesoporous Materials for Drug Delivery and Theranostics

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (30 April 2020) | Viewed by 37243

Printed Edition Available!
A printed edition of this Special Issue is available here.

Special Issue Editors


E-Mail Website
Guest Editor
Politecnico di Torino, Department of Applied Science and Technology, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
Interests: nanomedicine; nanotechnology; extracellular vesicles; zinc oxide; acoustic cavitation; ultrasound-assisted therapies; drug delivery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Applied Science & Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
Interests: drug delivery system; core–shell structures; nanostructured drug carrier; stimuli-responsive drug delivery; theranostics; micro-nanofluidics; sonodynamic therapy; multifunctional nanoparticles; metal oxides nanostructures; nano-acoustic contrast agents

Special Issue Information

Dear Colleagues,

Mesoporous materials, especially those made of silica, are capturing great interest thanks to their exceptional pore size and surface area and ease surface functionalization, thus enabling a broad series of intervention in the field of nanomedicine. For many years, these aspects have fostered a deep investigation of mesoporous nanoparticles to design and fabricate biocompatible, smart, and even mechanizable nanotools for controlled, stimuli-responsive drug or gene delivery up to the most recent theranostics applications, in particular for cancer therapy. 

This Special Issue of Pharmaceutics is dedicated to the most recent advances in the use of mesoporous micro- and nanostructures for designing novel “smart” biomedical systems applied to drug delivery and theranostics. Participation with research papers, short communications, and reviews focused on these topics and describing the synthesis and characterization of mesoporous materials, also in a core–shell configuration with other nanomaterials and their functionalization with smart and stimuli-responsive gatekeepers, as well as reporter molecules or particles for diagnostic applications and their final in vitro and in vivo applications in the nanomedicine field, is highly encouraged.

Prof. Valentina Cauda
Dr. Giancarlo Canavese
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • high porosity
  • colloidal dispersion
  • host–guest interaction
  • core–shell structures
  • surface functionalization
  • pore gatekeepers
  • stimuli-responsive drug delivery
  • cell targeting
  • gene therapy

Published Papers (9 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

3 pages, 161 KiB  
Editorial
Mesoporous Materials for Drug Delivery and Theranostics
by Valentina Cauda and Giancarlo Canavese
Pharmaceutics 2020, 12(11), 1108; https://doi.org/10.3390/pharmaceutics12111108 - 18 Nov 2020
Cited by 7 | Viewed by 1611
Abstract
Mesoporous materials, especially those made of silica or silicon, are capturing great interest in the field of nanomedicine [...] Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)

Research

Jump to: Editorial, Review

16 pages, 2241 KiB  
Article
Silicon Nanofluidic Membrane for Electrostatic Control of Drugs and Analytes Elution
by Nicola Di Trani, Antonia Silvestri, Yu Wang, Danilo Demarchi, Xuewu Liu and Alessandro Grattoni
Pharmaceutics 2020, 12(7), 679; https://doi.org/10.3390/pharmaceutics12070679 - 19 Jul 2020
Cited by 12 | Viewed by 3413
Abstract
Individualized long-term management of chronic pathologies remains an elusive goal despite recent progress in drug formulation and implantable devices. The lack of advanced systems for therapeutic administration that can be controlled and tailored based on patient needs precludes optimal management of pathologies, such [...] Read more.
Individualized long-term management of chronic pathologies remains an elusive goal despite recent progress in drug formulation and implantable devices. The lack of advanced systems for therapeutic administration that can be controlled and tailored based on patient needs precludes optimal management of pathologies, such as diabetes, hypertension, rheumatoid arthritis. Several triggered systems for drug delivery have been demonstrated. However, they mostly rely on continuous external stimuli, which hinder their application for long-term treatments. In this work, we investigated a silicon nanofluidic technology that incorporates a gate electrode and examined its ability to achieve reproducible control of drug release. Silicon carbide (SiC) was used to coat the membrane surface, including nanochannels, ensuring biocompatibility and chemical inertness for long-term stability for in vivo deployment. With the application of a small voltage (≤ 3 V DC) to the buried polysilicon electrode, we showed in vitro repeatable modulation of membrane permeability of two model analytes—methotrexate and quantum dots. Methotrexate is a first-line therapeutic approach for rheumatoid arthritis; quantum dots represent multi-functional nanoparticles with broad applicability from bio-labeling to targeted drug delivery. Importantly, SiC coating demonstrated optimal properties as a gate dielectric, which rendered our membrane relevant for multiple applications beyond drug delivery, such as lab on a chip and micro total analysis systems (µTAS). Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Graphical abstract

17 pages, 2512 KiB  
Article
Controlled Delivery of Insulin-like Growth Factor-1 from Bioactive Glass-Incorporated Alginate-Poloxamer/Silk Fibroin Hydrogels
by Qing Min, Xiaofeng Yu, Jiaoyan Liu, Yuchen Zhang, Ying Wan and Jiliang Wu
Pharmaceutics 2020, 12(6), 574; https://doi.org/10.3390/pharmaceutics12060574 - 20 Jun 2020
Cited by 14 | Viewed by 2750
Abstract
Thermosensitive alginate–poloxamer (ALG–POL) copolymer with an optimal POL content was synthesized, and it was used to combine with silk fibroin (SF) for building ALG–POL/SF hydrogels with dual network structure. Mesoporous bioactive glass (BG) nanoparticles (NPs) with a high level of mesoporosity and large [...] Read more.
Thermosensitive alginate–poloxamer (ALG–POL) copolymer with an optimal POL content was synthesized, and it was used to combine with silk fibroin (SF) for building ALG–POL/SF hydrogels with dual network structure. Mesoporous bioactive glass (BG) nanoparticles (NPs) with a high level of mesoporosity and large pore size were prepared and they were employed as a vehicle for loading insulin-like growth factor-1 (IGF-1). IGF-1-loaded BG NPs were embedded into ALG–POL/SF hydrogels to achieve the controlled delivery of IGF-1. The resulting IGF-1-loaded BG/ALG–POL/SF gels were found to be injectable with their sol-gel transition near physiological temperature and pH. Rheological measurements showed that BG/ALG–POL/SF gels had their elastic modulus higher than 5kPa with large ratio of elastic modulus to viscous modulus, indicative of their mechanically strong features. The dry BG/ALG–POL/SF gels were seen to be highly porous with well-interconnected pore characteristics. The gels loaded with varied amounts of IGF-1 showed abilities to administer IGF-1 release in approximately linear manners for a few weeks while effectively preserving the bioactivity of encapsulated IGF-1. Results suggest that such constructed BG/ALG–POL/SF gels can function as a promising injectable biomaterial for bone tissue engineering applications. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Graphical abstract

20 pages, 3932 KiB  
Article
Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles
by Lisa Haddick, Wei Zhang, Sören Reinhard, Karin Möller, Hanna Engelke, Ernst Wagner and Thomas Bein
Pharmaceutics 2020, 12(6), 505; https://doi.org/10.3390/pharmaceutics12060505 - 02 Jun 2020
Cited by 28 | Viewed by 3772
Abstract
Multifunctional core-shell mesoporous silica nanoparticles (MSN) were tailored in size ranging from 60 to 160 nm as delivery agents for antitumoral microRNA (miRNA). The positively charged particle core with a pore diameter of about 5 nm and a stellate pore morphology allowed for [...] Read more.
Multifunctional core-shell mesoporous silica nanoparticles (MSN) were tailored in size ranging from 60 to 160 nm as delivery agents for antitumoral microRNA (miRNA). The positively charged particle core with a pore diameter of about 5 nm and a stellate pore morphology allowed for an internal, protective adsorption of the fragile miRNA cargo. A negatively charged particle surface enabled the association of a deliberately designed block copolymer with the MSN shell by charge-matching, simultaneously acting as a capping as well as endosomal release agent. Furthermore, the copolymer was functionalized with the peptide ligand GE11 targeting the epidermal growth factor receptor, EGFR. These multifunctional nanoparticles showed an enhanced uptake into EGFR-overexpressing T24 bladder cancer cells through receptor-mediated cellular internalization. A luciferase gene knock-down of up to 65% and additional antitumoral effects such as a decreased cell migration as well as changes in cell cycle were observed. We demonstrate that nanoparticles with a diameter of 160 nm show the fastest cellular internalization after a very short incubation time of 45 min and produce the highest level of gene knock-down. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Graphical abstract

23 pages, 7511 KiB  
Article
Cell Theranostics on Mesoporous Silicon Substrates
by Maria Laura Coluccio, Valentina Onesto, Giovanni Marinaro, Mauro Dell’Apa, Stefania De Vitis, Alessandra Imbrogno, Luca Tirinato, Gerardo Perozziello, Enzo Di Fabrizio, Patrizio Candeloro, Natalia Malara and Francesco Gentile
Pharmaceutics 2020, 12(5), 481; https://doi.org/10.3390/pharmaceutics12050481 - 25 May 2020
Cited by 6 | Viewed by 3183
Abstract
The adhesion, proliferation, and migration of cells over nanomaterials is regulated by a cascade of biochemical signals that originate at the interface of a cell with a substrate and propagate through the cytoplasm to the nucleus. The topography of the substrate plays a [...] Read more.
The adhesion, proliferation, and migration of cells over nanomaterials is regulated by a cascade of biochemical signals that originate at the interface of a cell with a substrate and propagate through the cytoplasm to the nucleus. The topography of the substrate plays a major role in this process. Cell adhesion molecules (CAMs) have a characteristic size of some nanometers and a range of action of some tens of nanometers. Controlling details of a surface at the nanoscale—the same dimensional over which CAMs operate—offers ways to govern the behavior of cells and create organoids or tissues with heretofore unattainable precision. Here, using electrochemical procedures, we generated mesoporous silicon surfaces with different values of pore size (PS ≈ 11 nm and PS ≈ 21 nm), roughness (Ra ≈ 7 nm and Ra ≈ 13 nm), and fractal dimension (Df ≈ 2.48 and Df ≈ 2.15). Using electroless deposition, we deposited over these substrates thin layers of gold nanoparticles. Resulting devices feature (i) nanoscale details for the stimulation and control of cell assembly, (ii) arrays of pores for drug loading/release, (iii) layers of nanostructured gold for the enhancement of the electromagnetic signal in Raman spectroscopy (SERS). We then used these devices as cell culturing substrates. Upon loading with the anti-tumor drug PtCl (O,O′-acac)(DMSO) we examined the rate of adhesion and growth of breast cancer MCF-7 cells under the coincidental effects of surface geometry and drug release. Using confocal imaging and SERS spectroscopy we determined the relative importance of nano-topography and delivery of therapeutics on cell growth—and how an unbalance between these competing agents can accelerate the development of tumor cells. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Figure 1

20 pages, 3706 KiB  
Article
Injectable Thermosensitive Formulation Based on Polyurethane Hydrogel/Mesoporous Glasses for Sustained Co-Delivery of Functional Ions and Drugs
by Monica Boffito, Carlotta Pontremoli, Sonia Fiorilli, Rossella Laurano, Gianluca Ciardelli and Chiara Vitale-Brovarone
Pharmaceutics 2019, 11(10), 501; https://doi.org/10.3390/pharmaceutics11100501 - 01 Oct 2019
Cited by 32 | Viewed by 3581
Abstract
Mini-invasively injectable hydrogels are widely attracting interest as smart tools for the co-delivery of therapeutic agents targeting different aspects of tissue/organ healing (e.g., neo-angiogenesis, inflammation). In this work, copper-substituted bioactive mesoporous glasses (Cu-MBGs) were prepared as nano- and micro-particles and successfully loaded with [...] Read more.
Mini-invasively injectable hydrogels are widely attracting interest as smart tools for the co-delivery of therapeutic agents targeting different aspects of tissue/organ healing (e.g., neo-angiogenesis, inflammation). In this work, copper-substituted bioactive mesoporous glasses (Cu-MBGs) were prepared as nano- and micro-particles and successfully loaded with ibuprofen through an incipient wetness method (loaded ibuprofen approx. 10% w/w). Injectable hybrid formulations were then developed by dispersing ibuprofen-loaded Cu-MBGs within thermosensitive hydrogels based on a custom-made amphiphilic polyurethane. This procedure showed almost no effects on the gelation potential (gelation at 37 °C within 3–5 min). Cu2+ and ibuprofen were co-released over time in a sustained manner with a significantly lower burst release compared to MBG particles alone (burst release reduction approx. 85% and 65% for ibuprofen and Cu2+, respectively). Additionally, released Cu2+ species triggered polyurethane chemical degradation, thus enabling a possible tuning of gel residence time at the pathological site. The overall results suggest that hybrid injectable thermosensitive gels could be successfully designed for the simultaneous localized co-delivery of multiple therapeutics. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Figure 1

Review

Jump to: Editorial, Research

18 pages, 1196 KiB  
Review
Drug Delivery Applications of Three-Dimensional Printed (3DP) Mesoporous Scaffolds
by Tania Limongi, Francesca Susa, Marco Allione and Enzo di Fabrizio
Pharmaceutics 2020, 12(9), 851; https://doi.org/10.3390/pharmaceutics12090851 - 08 Sep 2020
Cited by 29 | Viewed by 5358
Abstract
Mesoporous materials are structures characterized by a well-ordered large pore system with uniform porous dimensions ranging between 2 and 50 nm. Typical samples are zeolite, carbon molecular sieves, porous metal oxides, organic and inorganic porous hybrid and pillared materials, silica clathrate and clathrate [...] Read more.
Mesoporous materials are structures characterized by a well-ordered large pore system with uniform porous dimensions ranging between 2 and 50 nm. Typical samples are zeolite, carbon molecular sieves, porous metal oxides, organic and inorganic porous hybrid and pillared materials, silica clathrate and clathrate hydrates compounds. Improvement in biochemistry and materials science led to the design and implementation of different types of porous materials ranging from rigid to soft two-dimensional (2D) and three-dimensional (3D) skeletons. The present review focuses on the use of three-dimensional printed (3DP) mesoporous scaffolds suitable for a wide range of drug delivery applications, due to their intrinsic high surface area and high pore volume. In the first part, the importance of the porosity of materials employed for drug delivery application was discussed focusing on mesoporous materials. At the end of the introduction, hard and soft templating synthesis for the realization of ordered 2D/3D mesostructured porous materials were described. In the second part, 3DP fabrication techniques, including fused deposition modelling, material jetting as inkjet printing, electron beam melting, selective laser sintering, stereolithography and digital light processing, electrospinning, and two-photon polymerization were described. In the last section, through recent bibliographic research, a wide number of 3D printed mesoporous materials, for in vitro and in vivo drug delivery applications, most of which relate to bone cells and tissues, were presented and summarized in a table in which all the technical and bibliographical details were reported. This review highlights, to a very cross-sectional audience, how the interdisciplinarity of certain branches of knowledge, as those of materials science and nano-microfabrication are, represent a growing valuable aid in the advanced forum for the science and technology of pharmaceutics and biopharmaceutics. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Graphical abstract

33 pages, 1416 KiB  
Review
Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy
by Sugata Barui and Valentina Cauda
Pharmaceutics 2020, 12(6), 527; https://doi.org/10.3390/pharmaceutics12060527 - 08 Jun 2020
Cited by 41 | Viewed by 7431
Abstract
The presence of leaky vasculature and the lack of lymphatic drainage of small structures by the solid tumors formulate nanoparticles as promising delivery vehicles in cancer therapy. In particular, among various nanoparticles, the mesoporous silica nanoparticles (MSN) exhibit numerous outstanding features, including mechanical [...] Read more.
The presence of leaky vasculature and the lack of lymphatic drainage of small structures by the solid tumors formulate nanoparticles as promising delivery vehicles in cancer therapy. In particular, among various nanoparticles, the mesoporous silica nanoparticles (MSN) exhibit numerous outstanding features, including mechanical thermal and chemical stability, huge surface area and ordered porous interior to store different anti-cancer therapeutics with high loading capacity and tunable release mechanisms. Furthermore, one can easily decorate the surface of MSN by attaching ligands for active targeting specifically to the cancer region exploiting overexpressed receptors. The controlled release of drugs to the disease site without any leakage to healthy tissues can be achieved by employing environment responsive gatekeepers for the end-capping of MSN. To achieve precise cancer chemotherapy, the most desired delivery system should possess high loading efficiency, site-specificity and capacity of controlled release. In this review we will focus on multimodal decorations of MSN, which is the most demanding ongoing approach related to MSN application in cancer therapy. Herein, we will report about the recently tried efforts for multimodal modifications of MSN, exploiting both the active targeting and stimuli responsive behavior simultaneously, along with individual targeted delivery and stimuli responsive cancer therapy using MSN. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Figure 1

42 pages, 7937 KiB  
Review
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
by Rafael R. Castillo, Daniel Lozano and María Vallet-Regí
Pharmaceutics 2020, 12(5), 432; https://doi.org/10.3390/pharmaceutics12050432 - 07 May 2020
Cited by 68 | Viewed by 5465
Abstract
The enormous versatility of mesoporous silica nanoparticles permits the creation of a large number of nanotherapeutic systems for the treatment of cancer and many other pathologies. In addition to the controlled release of small drugs, these materials allow a broad number of molecules [...] Read more.
The enormous versatility of mesoporous silica nanoparticles permits the creation of a large number of nanotherapeutic systems for the treatment of cancer and many other pathologies. In addition to the controlled release of small drugs, these materials allow a broad number of molecules of a very different nature and sizes. In this review, we focus on biogenic species with therapeutic abilities (proteins, peptides, nucleic acids, and glycans), as well as how nanotechnology, in particular silica-based materials, can help in establishing new and more efficient routes for their administration. Indeed, since the applicability of those combinations of mesoporous silica with bio(macro)molecules goes beyond cancer treatment, we address a classification based on the type of therapeutic action. Likewise, as illustrative content, we highlight the most typical issues and problems found in the preparation of those hybrid nanotherapeutic materials. Full article
(This article belongs to the Special Issue Mesoporous Materials for Drug Delivery and Theranostics)
Show Figures

Graphical abstract

Back to TopTop